Double hit lymphomas with BCL2 and MYC translocations, other double‐expressor lymphomas that overexpress Bcl2 and Myc proteins, and lymphomas containing genomic aberrations in the TP53 gene also have inferior outcome [8, 9, 10, 11, 12]. The gene discussed is MYC; the disease is lymphoma.